ECZEMA
Clinical trials for ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ECZEMA trials appear
Sign up with your email to follow new studies for ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a 'Friendly Bacteria' lotion keep Kids' eczema at bay?
Disease control CompletedThis study tested whether a moisturizer containing postbiotics (substances from 'friendly' bacteria and yeast) could help prevent eczema from coming back in children aged 0-6 years. It compared this special lotion to stopping moisturizer use entirely after getting the eczema unde…
Matched conditions: ECZEMA
Phase: NA • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug tested for severe skin rash and itch
Disease control CompletedThis study tested a new drug called camoteskimab for adults with moderate to severe eczema (atopic dermatitis). For the first 16 weeks, some participants received the drug and others received a placebo, then everyone received the drug. The main goal was to see if the drug safely …
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New injection shows promise for controlling severe eczema flares
Disease control CompletedThis study tested whether an intravenous medication called EVO301 could help control moderate to severe eczema in adults. 71 participants with significant eczema covering at least 10% of their body received either the drug or a placebo. Researchers measured changes in skin severi…
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Virtual doctor visits tested for common skin condition
Disease control CompletedThis study tested whether managing eczema through an online team of doctors works as well as traditional in-person visits. 300 patients with eczema were randomly assigned to either use the online system or continue with regular office appointments for one year. Researchers compar…
Matched conditions: ECZEMA
Phase: NA • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists peek inside skin to see how eczema drug works
Knowledge-focused CompletedThis study aimed to understand how the approved eczema medication dupilumab changes the immune environment and gene activity in the skin over time. Seventeen adults with moderate-to-severe eczema received dupilumab injections for a year. Researchers took small skin samples to ana…
Matched conditions: ECZEMA
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Scientists probe hidden pathway behind eczema itch
Knowledge-focused CompletedThis study aimed to understand how a specific molecule called PGE2 might drive inflammation in eczema. Researchers analyzed skin and blood samples from 38 people with eczema, psoriasis, and healthy volunteers to see if blocking this pathway could be a future treatment strategy. T…
Matched conditions: ECZEMA
Sponsor: NHS Lothian • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:03 UTC